BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5066752)

  • 1. Alprenolol treatment of angina pectoris.
    Nyberg KG
    JAMA; 1972 Apr; 220(1):128. PubMed ID: 5066752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of alprenolol in the treatment of angina pectoris].
    Lippenholtz A; Talmasky S; Berconsky I
    Prensa Med Argent; 1969 Sep; 56(27):1357-61. PubMed ID: 4391256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aptin, Hässle (Alprenolol)].
    Saunamäki K
    Ugeskr Laeger; 1969 Sep; 131(36):1527-9. PubMed ID: 5356458
    [No Abstract]   [Full Text] [Related]  

  • 4. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol.
    Dagenais GR; Pitt B; Ross RS
    Am J Cardiol; 1971 Jul; 28(1):10-6. PubMed ID: 4397511
    [No Abstract]   [Full Text] [Related]  

  • 7. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 9. Alprenolol in resuscitation.
    Pontinen J; Eggert H; Kemila S
    Br Med J; 1971 Dec; 4(5789):723. PubMed ID: 4399701
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris.
    Sharma B; Taylor SH
    Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578
    [No Abstract]   [Full Text] [Related]  

  • 11. A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study.
    Forrest WA
    Br J Clin Pract; 1972 May; 26(5):217-22. PubMed ID: 4625606
    [No Abstract]   [Full Text] [Related]  

  • 12. Alprenolol treatment of angina pectoris.
    Lyon LJ; Nevins MA
    JAMA; 1971 Mar; 215(10):1669. PubMed ID: 4395863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
    Reynolds JL; Whitlock RM
    Br Heart J; 1972 Mar; 34(3):252-9. PubMed ID: 4111391
    [No Abstract]   [Full Text] [Related]  

  • 15. Angina pectoris.
    Taylor SH
    Br Med J; 1971 Jun; 2(5763):713. PubMed ID: 4253966
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term clinical results of oxprenolol in the treatment of cardiac arrhythmias, angina pectoris and hypertrophic subaortic stenosis.
    Scebat L; Bensaid J
    Postgrad Med J; 1970 Nov; ():Suppl:86-90. PubMed ID: 4395465
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-blocking agents in angina pectoris. A double-blind trial].
    Aubert AB; Nyberg G; Slaastad R; Tjeldflaat L
    Tidsskr Nor Laegeforen; 1970 Feb; 90(4):409-13 passim. PubMed ID: 4393271
    [No Abstract]   [Full Text] [Related]  

  • 18. -Receptor antagonists in angina pectoris.
    Prichard BN
    Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of alprenolol in the prevention of paroxysmal cardiac arrhythmias].
    Pasini U; Netto MP; Diament J; Valada L
    Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(4):173-6. PubMed ID: 5056447
    [No Abstract]   [Full Text] [Related]  

  • 20. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.